Pharmaceutical industry

GSK Vaccines GmbH at its Marburg site (Projekt MMP)

With an investment of 162 million EUR, GSK is expanding its range of vaccines produced at its location in Marburg with the construction of a new plant for an additional component of the meningococcal B vaccine.

Together with Siemens AG, Stadler + Schaaf was tasked with implementing the control system for ventilation and media distribution via a virtualised PCS7 System V9. S + S is responsible for the planning and construction of the required controller cabinets, RIOs and power cabinets. After Stadler + Schaaf prepared the functional description, implementation is to be carried out together with Siemens AG. Stadler + Schaaf will accompany the works through to qualification.